Results 181 to 190 of about 644,703 (404)

Advancing laboratory animal science in the Philippines: PALAS initiatives and partnerships leading to Asia Laboratory Animal Day 2025

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Abstract As the Philippines celebrated the 2nd Asia Laboratory Animal Day (ALAD) last November 29, 2025, the Philippine Association for Laboratory Animal Sciences (PALAS) reflected on a year marked by growth, collaboration, and renewed commitment to ethical and scientific excellence in animal‐based research.
Rodel Jonathan S. Vitor II   +10 more
wiley   +1 more source

Trametinib in Adults with Neurofibromatosis Type 1‐Related Symptomatic Plexiform Neurofibromas

open access: yesAnnals of Neurology, EarlyView.
Objective Mitogen‐activated protein kinase kinase inhibitors have shown promising results in treatment of plexiform neurofibromas in neurofibromatosis type 1 patients, but data in adults are limited. The aim of this phase 2 study was to investigate the efficacy and safety of trametinib in adults with neurofibromatosis type 1.
D. Christine Noordhoek   +7 more
wiley   +1 more source

Antibacterial Applications of Black and Violet Phosphorus‐Based Biomaterials

open access: yesAdvanced NanoBiomed Research, EarlyView.
Black and violet phosphorus‐based biomaterials exhibit broad‐spectrum antibacterial efficacy in various infections, including bone, skin, ocular, dental, lung, and sepsis cases. Their antibacterial mechanisms include physical disruption, light‐driven effects, targeted drug delivery, and enhanced composite strategies.
Zhuo Dai   +8 more
wiley   +1 more source

Trends in Opioid Analgesic-Prescribing Rates by Specialty, U.S., 2007-2012.

open access: yesAmerican Journal of Preventive Medicine, 2015
Benjamin Levy   +3 more
semanticscholar   +1 more source

Decoding the Pathophysiology of Autoimmune Diseases—Mechanism, Triggers, and Nanotherapeutics: A Review

open access: yesAdvanced NanoBiomed Research, EarlyView.
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari   +5 more
wiley   +1 more source

Skin permeability and analgesic activity effects of verbenone hydrazones

open access: hybrid, 2020
Mariia Nesterkina   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy